The MPP Association aims to enhance interactions between pharma, medtech and tech industries, in order to promote product development and innovation.
Basel, Switzerland
Joined June 2014
- Tweets801
- Following296
- Followers274
- Likes91
The challenges for the #MDR implementation can only be solved by all stakeholders together, says Stephan Affolter, Medtech & Pharma Platform Association (MPP) Board Member.
1
1
What are the main challenges for connected combined products (CCPs)?
➡️Components can have different purposes, regulatory classifications, safety profile & risk levels
➡️Lack of clarity on the stakeholders’ roles & responsibilities
What are connected #CombinedProducts?
➡️Combined use, for a medical purpose, of a medicinal product and medical device / IVD with #DigitalHealth components such as:
-Smartphone applications
-Cloud storage systems
-Cloud-based services
The Medtech & Pharma Platform Association (MPP) advocates for a clear and balanced framework for #CombinedProducts, says MPP Board Member Daniel Delfosse.
#Pharma #Medtech #Tech
1
The Medtech & Pharma Platform Association (MPP) is a unique association in Europe, bringing together #Pharma, #Medtech and #Tech companies, says the MPP President Shayesteh Fürst-Ladani.
#CombinedProducts
The 🇪🇺EU is seeking to tap the potential of health data for healthcare and regulatory decision-making via the #EHDS.
➡️The MPP supports the development of technologies combining medicinal products, medical devices and digital health components: bit.ly/3TeiQTE
The MPP is the only European industry association bringing together companies from
💊 #Pharma
🔬 #Medtech
📱 #Tech
to foster synergies and address challenges for the regulation and development of #CombinedProducts.
The European Commission adopted proposals to adapt the #EU liability rules to the digital age:
-Product Liability Directive revision
-AI Liability Directive
A clear framework is essential to support healthcare digitalization & the development of innovative health products.
Have you read our latest paper on the regulation and development of connected combined products?
bit.ly/3SCRUMO
The paper identifies challenges and best practices for the combined use of drug, device and digital components. Reach out to us to start the discussion.
Join the only European industry association focusing on the combined use of drug, device and digital components for a medical purpose.
➡️Help us identify barriers to product development, best practices and solutions to bridge the gap between the different frameworks.
The #MPP2022 conference report, including key take home messages, is now available on our website! Take a look and learn more about the discussions in the panel and the expert sessions.
The full report is available here: bit.ly/3S61mbr
1
The integration of digital technologies in medicinal product and medical device combinations remains challenging.
➡️Join the #MPP to share your experience, exchange best practices and identify potential solutions to streamline the framework for #CombinedProducts in the #EU.
Thank you for making MPP 2022 a success!
The next edition of the MPP annual conference will take place in September 2023. Follow us on social media to stay informed about our upcoming events and activities.
MPP’s President Shayesteh Fürst-Ladani is closing the 9th MPP Annual Conference. Participants heard expert insights, engaged in discussions on key topics for the development of combined products and met stakeholders from the medtech, pharma and tech sectors.
Participants at MPP 2022 are hearing insights from Lada Leyens from @Roche on digital endpoints and the impact of digital health technologies for clinical research. #CombinedProducts #MPP2022 #Pharma #Medtech
3
Iain Simpson from @PhillipsMedisiz is exploring how connected combined products can help improve adherence in clinical trials. #CombinedProducts #MPP2022 #Pharma #Medtech
Antoine Bourrier from @Capgemini is providing perspectives on the challenges linked to healthcare digital innovation with the MPP 2022 audience. #CombinedProducts #MPP2022 #Pharma #Medtech
